# OnCo record france-early-access (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/france-early-access/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "france-early-access" ;
  schema:name "France: early access (accès précoce), formerly ATU"@en ;
  schema:alternateName "accès précoce"@en, "acces precoce"@en, "ATU"@en, "autorisation temporaire d'utilisation"@en, "temporary authorisation for use"@en, "accès compassionnel"@en, "compassionate access France"@en, "early access authorisation"@en ;
  schema:description "France pays for promising medicines before they are approved or reimbursed: the ATU system did this from 1994, and since July 2021 the Haute Autorité de Santé grants early access for presumed innovative drugs in serious diseases, with the company setting the price and repaying the difference later."@en ;
  schema:url <https://onco.cc/terms/france-early-access/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.has-sante.fr/jcms/p_3277085/fr/acces-precoce> ;
  onco:tag "law", "fr" ;
  onco:related <https://onco.cc/terms/expanded-access/>, <https://onco.cc/terms/hta/>, <https://onco.cc/terms/conditional-approval/>, <https://onco.cc/terms/eu-regulation-726-2004/>, <https://onco.cc/terms/amnog/>, <https://onco.cc/terms/real-world-evidence/>, <https://onco.cc/terms/ilap/>, <https://onco.cc/terms/eu-hta-regulation/> ;
  onco:institutions <https://onco.cc/institutions/has-france/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-global-access/>, <https://onco.cc/bottlenecks/b-real-world-evidence/> .